Rusty Rahmer
CX/Digital Transformation Leader
Rusty Rahmersecurehost2025-02-26T20:47:12+00:00
FEBRUARY 2025
In this DHCG Disruptive Dose, Mark Bard of The DHC Group sits down with Rusty Rahmer to discuss pharma’s digital evolution, accelerated post-pandemic. They explore the shift from blockbuster drugs to targeted biopharma and the role of digital in reaching smaller patient populations. Rahmer highlights challenges in executing C-suite transformation goals, accountability gaps among vendors and teams, and the need for integrated marketing, analytics, and technology for real impact.